CTT Pharmaceutical Holdings, Inc. CTTH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | 66.30% | -187.12% | -7.25% | ||
| Total Depreciation and Amortization | 6.25% | 6.25% | -75.00% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -98.02% | -- | 111.89% | ||
| Change in Net Operating Assets | 154.21% | 205.41% | 23.17% | ||
| Cash from Operations | 70.29% | 39.56% | 93.30% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -- | -- | ||
| Total Debt Issued | -- | -- | -660.95% | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -100.00% | -86.50% | -57.38% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -100.00% | -86.50% | -100.04% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -143.83% | -117.15% | -15,300.00% | ||